{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:57:39Z","timestamp":1792803459014,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is a progressive autoimmune disorder that mainly affects the skin. There are other clinical manifestations as renal, pulmonary, cardiovascular, and gastrointestinal tract involvements. Based on the skin involvement there are two subtypes of SSc, as limited cutaneous SSc (lSSc) which involves the acral part of the body and diffuse cutaneous SSc (dSSc) resulting in significant skin thickening of the body. Despite of the extensive research the pathomechanism is not fully clarified, how Ssc develops, moreover identifying biomarkers to predict the clinical outcome and prognosis still remains challenging. Circulating biomarkers can be crucial to define the diagnosis, to predict the prognosis and monitor the clinical course. However, only some patients are responsive to the therapy in SSc, and there is a need to reach the ideal therapy for any individual to prevent or slow down the progression in early stages of the disease. In this narrative review, our purpose was to summarize the potential biomarkers in Ssc, describe their role in the diagnosis, pathomechanism, clinical course, organ manifestations, as well as the response to the therapy. Biomarkers assessment aids in the evaluation of disease progression, and disease outcome.<\/jats:p>","DOI":"10.1007\/s10067-024-07123-y","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T16:02:36Z","timestamp":1724947356000},"page":"3055-3072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-9395","authenticated-orcid":false,"given":"Anna","family":"Bazs\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"7123_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/kjm2.12505","volume":"38","author":"A Rosendahl","year":"2022","unstructured":"Rosendahl A, Sch\u00f6nborn K, Krieg T (2022) Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci 38:187\u2013195. https:\/\/doi.org\/10.1002\/kjm2.12505","journal-title":"Kaohsiung J Med Sci"},{"key":"7123_CR2","doi-asserted-by":"publisher","first-page":"103314","DOI":"10.1016\/j.autrev.2023.213324","volume":"22","author":"S Keret","year":"2023","unstructured":"Keret S, Rimar D, Lansiaux P et al (2023) Differentially expressed genes in systemic sclerosis: towards predictive medicine with new molecular tools for clinicians. Autoimmun Rev 22:103314. https:\/\/doi.org\/10.1016\/j.autrev.2023.213324","journal-title":"Autoimmun Rev"},{"key":"7123_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1073\/pnas.1906593116","volume":"117","author":"P Gourh","year":"2020","unstructured":"Gourh P, Safran SA, Alexander T et al (2020) HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci 117:552\u2013562. https:\/\/doi.org\/10.1073\/pnas.1906593116","journal-title":"Proc Natl Acad Sci"},{"key":"7123_CR4","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1038\/s41598-021-99292-y","volume":"11","author":"G Abignano","year":"2021","unstructured":"Abignano G, Hermes H, Piera-Velazquez S et al (2021) Global gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF genes. Sci Rep 11:20435. https:\/\/doi.org\/10.1038\/s41598-021-99292-y","journal-title":"Sci Rep"},{"key":"7123_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","volume":"41","author":"EP Stern","year":"2015","unstructured":"Stern EP, Denton CP (2015) The pathogenesis of systemic sclerosis. Rheum Dis Clin North Am 41:367\u2013382. https:\/\/doi.org\/10.1016\/j.rdc.2015.04.002","journal-title":"Rheum Dis Clin North Am"},{"key":"7123_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/art.41657","volume":"73","author":"M Kerick","year":"2021","unstructured":"Kerick M, Gonz\u00e1lez-Serna D, Carnero-Montoro E et al (2021) Expression quantitative trait locus analysis in systemic sclerosis identifies new candidate genes associated with multiple aspects of disease pathology. Arthritis Rheumatol 73:1288\u20131300. https:\/\/doi.org\/10.1002\/art.41657","journal-title":"Arthritis Rheumatol"},{"key":"7123_CR7","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/art.11220","volume":"48","author":"X Zhou","year":"2003","unstructured":"Zhou X, Tan FK, Wang N et al (2003) Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum 48:2585\u20132592. https:\/\/doi.org\/10.1002\/art.11220","journal-title":"Arthritis Rheum"},{"key":"7123_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/annrheumdis-2019-216542","volume":"79","author":"CW Wasson","year":"2020","unstructured":"Wasson CW, Abignano G, Hermes H et al (2020) Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann Rheum Dis 79:507\u2013517. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216542","journal-title":"Ann Rheum Dis"},{"key":"7123_CR9","doi-asserted-by":"publisher","first-page":"103143","DOI":"10.1016\/j.isci.2021.103143","volume":"24","author":"AE Fearon","year":"2021","unstructured":"Fearon AE, Slabber CF, Kuklin A et al (2021) Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis. iScience 24:103143. https:\/\/doi.org\/10.1016\/j.isci.2021.103143","journal-title":"iScience"},{"key":"7123_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","volume":"15","author":"M Cutulo","year":"2019","unstructured":"Cutulo M, Soldano S, Smith S (2019) Pathophysiology of systemic sclerosis: current understanding and newinsight. Expert Rev Clin Immunol 15:753\u2013764. https:\/\/doi.org\/10.1080\/1744666X.2019.1614915","journal-title":"Expert Rev Clin Immunol"},{"key":"7123_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00281-015-0509-1","volume":"37","author":"C Chizzolini","year":"2015","unstructured":"Chizzolini C, Boin F (2015) The role of the acquired immune response in systemic sclerosis. Semin Immunopathol 37:519\u2013528. https:\/\/doi.org\/10.1007\/s00281-015-0509-1","journal-title":"Semin Immunopathol"},{"key":"7123_CR12","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/jcm9092687","volume":"9","author":"Y Asano","year":"2020","unstructured":"Asano Y (2020) The pathogenesis of systemic sclerosis: an understanding based on common pathologic cascade across multiple organs and additional organ-specific pathologies. J Clin Med 9:2687. https:\/\/doi.org\/10.3390\/jcm9092687","journal-title":"J Clin Med"},{"key":"7123_CR13","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.berh.2019.101428","volume":"33","author":"S Bellando-Randone","year":"2019","unstructured":"Bellando-Randone S, Matucci-Cerinic M (2019) Very early systemic sclerosis. Best Pract Res Clin Rheumatol 33:101428. https:\/\/doi.org\/10.1016\/j.berh.2019.101428","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"7123_CR14","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","volume":"15","author":"C Frantz","year":"2018","unstructured":"Frantz C, Auffray C, Avouac J (2018) Regulatory T cells in systemic sclerosis. Font Immunol 15(9):2356. https:\/\/doi.org\/10.3389\/fimmu.2018.02356","journal-title":"Font Immunol"},{"key":"7123_CR15","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/rheumatology\/keac578","volume":"62","author":"LI Sakkas","year":"2023","unstructured":"Sakkas LI, Katsiari CG, Daoussis D, Bogdanos DP (2023) The role of B cells in the pathogenesis of systemic sclerosis: an update. Rheumatology 62:1780\u20131786. https:\/\/doi.org\/10.1093\/rheumatology\/keac578","journal-title":"Rheumatology"},{"key":"7123_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2017.00018","volume":"8","author":"S Negrini","year":"2017","unstructured":"Negrini S, Fenoglio D, Parodi A et al (2017) Phenotypic alterations involved in CD8+ treg impairment in systemic sclerosis. Front Immunol 8:18. https:\/\/doi.org\/10.3389\/fimmu.2017.00018","journal-title":"Front Immunol"},{"key":"7123_CR17","doi-asserted-by":"publisher","first-page":"eaam845","DOI":"10.1126\/scitranslmed.aam8458","volume":"10","author":"MD Ah Kioon","year":"2018","unstructured":"Ah Kioon MD, Tripodo C, Fernandez D et al (2018) Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci Transl Med 10:eaam845. https:\/\/doi.org\/10.1126\/scitranslmed.aam8458","journal-title":"Sci Transl Med"},{"key":"7123_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.170.3.727","volume":"170","author":"N Khalil","year":"1989","unstructured":"Khalil N, Bereznay O, Sporn M, Greenberg AH (1989) Macrophage production of transforming growth factor \u03b2 and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170:737\u2013737. https:\/\/doi.org\/10.1084\/jem.170.3.727","journal-title":"J Exp Med"},{"key":"7123_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","volume":"19","author":"AC Trombetta","year":"2018","unstructured":"Trombetta AC, Soldano S, Contini P et al (2018) A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res 19:186. https:\/\/doi.org\/10.1186\/s12931-018-0891-z","journal-title":"Respir Res"},{"key":"7123_CR20","doi-asserted-by":"publisher","unstructured":"Rech TF, Moraes SBC, Bredemeier M, et al (2016) Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis. Genet Mol Res 15. https:\/\/doi.org\/10.4238\/gmr15049077.","DOI":"10.4238\/gmr15049077"},{"key":"7123_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano Y, Sato S (2015) Vasculopathy in scleroderma. Semin Immunopathol 37:489\u2013500. https:\/\/doi.org\/10.1007\/s00281-015-0505-5","journal-title":"Semin Immunopathol"},{"key":"7123_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ et al (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170:1807\u20131816. https:\/\/doi.org\/10.2353\/ajpath.2007.070112","journal-title":"Am J Pathol"},{"key":"7123_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2:11\u201318. https:\/\/doi.org\/10.5301\/jsrd.5000231","journal-title":"J Scleroderma Relat Disord"},{"key":"7123_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","volume":"87","author":"R Jerjen","year":"2022","unstructured":"Jerjen R, Nikpour M, Krieg T et al (2022) Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. J Am Acad Dermatol 87:937\u2013954. https:\/\/doi.org\/10.1016\/j.jaad.2021.10.065","journal-title":"J Am Acad Dermatol"},{"key":"7123_CR25","doi-asserted-by":"publisher","first-page":"151947","DOI":"10.1016\/j.semarthrit.2021.11.013","volume":"52","author":"A Riccardi","year":"2022","unstructured":"Riccardi A, Martinroche G, Contin-Bordes C et al (2022) Erosive arthritis autoantibodies in systemic sclerosis. Semin Arthritis Rheum 52:151947. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.11.013","journal-title":"Semin Arthritis Rheum"},{"key":"7123_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.55563\/clinexprheumatol\/vggbdq","volume":"39","author":"A Sakchaikul","year":"2021","unstructured":"Sakchaikul A, Chowchuen P, Foocharoen C, Thammaroj P (2021) Prevalence and clinical association with acro-osteolysis in early systemic sclerosis. Clin Exp Rheumatol 39:1093\u20131098. https:\/\/doi.org\/10.55563\/clinexprheumatol\/vggbdq","journal-title":"Clin Exp Rheumatol"},{"key":"7123_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13760-018-1048-z","volume":"121","author":"P Ostojic","year":"2021","unstructured":"Ostojic P, Knezevic-Apostolski S, Djurovic N et al (2021) Neurological and electroneurography findings in patients with systemic sclerosis and symptoms of neuropathic pain in extremities. Acta Neurol Belg 121:205\u2013209. https:\/\/doi.org\/10.1007\/s13760-018-1048-z","journal-title":"Acta Neurol Belg"},{"key":"7123_CR28","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.berth.2023.101849","volume":"37","author":"V Smith","year":"2023","unstructured":"Smith V, Ickinger C, Hysa E et al (2023) Naifold capillaroscopy. Best Pact Res Clin Rheumatol 37:101849. https:\/\/doi.org\/10.1016\/j.berth.2023.101849","journal-title":"Best Pact Res Clin Rheumatol"},{"key":"7123_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/14397595.2021.1886654","volume":"31","author":"C Muktabhant","year":"2021","unstructured":"Muktabhant C, Thammaroj P, Chowchuen P, Foocharoen C (2021) Prevalence and clinical association with calcinosis cutis in early systemic sclerosis. Mod Rheumatol 31:1113\u20131119. https:\/\/doi.org\/10.1080\/14397595.2021.1886654","journal-title":"Mod Rheumatol"},{"key":"7123_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.semarthrit.2019.11.008","volume":"50","author":"S Chatterjee","year":"2020","unstructured":"Chatterjee S, Prayson RA (2020) Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis\u2014report of two cases and review of the literature. Semin Arthritis Rheum 50:498\u2013502. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.11.008","journal-title":"Semin Arthritis Rheum"},{"key":"7123_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/acr.21716","volume":"64","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Harding S, Khimdas S et al (2012) Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res 64:1405\u20131414. https:\/\/doi.org\/10.1002\/acr.21716","journal-title":"Arthritis Care Res"},{"key":"7123_CR32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/art.41732","volume":"73","author":"A Young","year":"2021","unstructured":"Young A, Moles VM, Jaafar S et al (2021) Performance of the DETECT algorithm for pulmonary hypertension screening in a systemic sclerosis cohort. Arthritis Rheumatol 73:1731\u20131737. https:\/\/doi.org\/10.1002\/art.41732","journal-title":"Arthritis Rheumatol"},{"key":"7123_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP et al (2012) An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185:1004\u20131014. https:\/\/doi.org\/10.1164\/rccm.201202-0320ST","journal-title":"Am J Respir Crit Care Med"},{"key":"7123_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-021-02505-y","volume":"23","author":"L Ma","year":"2021","unstructured":"Ma L, Zhu Q, Zhang Y et al (2021) Esophagus involvement in systemic sclerosis: ultrasound parameters and association with clinical manifestations. Arthritis Res Ther 23:122. https:\/\/doi.org\/10.1186\/s13075-021-02505-y","journal-title":"Arthritis Res Ther"},{"key":"7123_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB (2022) The gut microbiome and inflammatory bowel diseases. Annu Rev Med 73:455\u2013468. https:\/\/doi.org\/10.1146\/annurev-med-042320-021020","journal-title":"Annu Rev Med"},{"key":"7123_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/jpm13040678","volume":"13","author":"A Stec","year":"2023","unstructured":"Stec A, Maciejewska M, Zaremba M et al (2023) The clinical significance of serum biomarkers of the intestinal barrier in systemic sclerosis: a cross-sectional study. J Pers Med 13:678. https:\/\/doi.org\/10.3390\/jpm13040678","journal-title":"J Pers Med"},{"key":"7123_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/1744666X.2023.2161512","volume":"19","author":"Y Kawagachi","year":"2023","unstructured":"Kawagachi Y, Kuwana M (2023) Is there a role for the microbiome in systemic sclerosis? Expert Rev Clin Immunol 19:237\u2013240. https:\/\/doi.org\/10.1080\/1744666X.2023.2161512","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"7123_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5195\/jmla.2018.283","volume":"106","author":"WM Bramer","year":"2018","unstructured":"Bramer WM (2018) A systemic approach to searching: an efficient and complete method to develop literature searches. J Med Libr Assoc 106(4):531\u2013541. https:\/\/doi.org\/10.5195\/jmla.2018.283","journal-title":"J Med Libr Assoc"},{"key":"7123_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cca.2013.09.018","volume":"427","author":"AR Horvath","year":"2014","unstructured":"Horvath AR, Lord SJ, StJohn A et al (2014) From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta 427:49\u201357. https:\/\/doi.org\/10.1016\/j.cca.2013.09.018","journal-title":"Clin Chim Acta"},{"key":"7123_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","volume":"58","author":"A Stochmal","year":"2020","unstructured":"Stochmal A, Czuwara J, Trojanowska M, Rudnicka L (2020) Antinuclear antibodies in systemic sclerosis: an update. Clin Rev Allergy Immunol 58:40\u201351. https:\/\/doi.org\/10.1007\/s12016-018-8718-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"7123_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2466-9-18","volume":"9","author":"AI Papaioannou","year":"2009","unstructured":"Papaioannou AI, Zakynthinos E, Kostikas K et al (2009) Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med 9:18. https:\/\/doi.org\/10.1186\/1471-2466-9-18","journal-title":"BMC Pulm Med"},{"key":"7123_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-022-02787-w","volume":"24","author":"M Rokni","year":"2022","unstructured":"Rokni M, Sadeghi Shaker M, Kavosi H et al (2022) The role of endothelin and RAS\/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications. Arthritis Res Ther 24:108. https:\/\/doi.org\/10.1186\/s13075-022-02787-w","journal-title":"Arthritis Res Ther"},{"key":"7123_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157339710904140417124819","volume":"9","author":"S Bellando-Randone","year":"2014","unstructured":"Bellando-Randone S, Matucci-Cerinic M (2014) From Raynaud\u2019s phenomenon to very early diagnosis of systemic sclerosis\u2014the VEDOSS approach. Curr Rheumatol Rev 9:245\u2013248. https:\/\/doi.org\/10.2174\/157339710904140417124819","journal-title":"Curr Rheumatol Rev"},{"key":"7123_CR44","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.3391\/ijms241814385","volume":"24","author":"E Patnaik","year":"2023","unstructured":"Patnaik E, Lyons M, Tran K, Pattanaik D (2023) Endotheial dysfunction in systemic sclerosis. Int J Mol Sci 24:14385. https:\/\/doi.org\/10.3391\/ijms241814385","journal-title":"Int J Mol Sci"},{"key":"7123_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/ar628","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80\u201393. https:\/\/doi.org\/10.1186\/ar628","journal-title":"Arthritis Res Ther"},{"key":"7123_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00296-009-0868-9","volume":"29","author":"A Volpe","year":"2009","unstructured":"Volpe A, Ruzzenente O, Caramaschi P et al (2009) Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis. Rheumatol Int 29:1073\u20131079. https:\/\/doi.org\/10.1007\/s00296-009-0868-9","journal-title":"Rheumatol Int"},{"key":"7123_CR47","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005\u20131013. https:\/\/doi.org\/10.7326\/0003-4819-119-10-199311150-00007","journal-title":"Ann Intern Med"},{"key":"7123_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/315179","volume":"2014","author":"M Mahler","year":"2014","unstructured":"Mahler M, Meroni P-L, Bossuyt X, Fritzler MJ (2014) Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014:1\u201318. https:\/\/doi.org\/10.1155\/2014\/315179","journal-title":"J Immunol Res"},{"key":"7123_CR49","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/art.39755","volume":"68","author":"ZE Betteridge","year":"2016","unstructured":"Betteridge ZE, Woodhead F, Lu H et al (2016) Brief report: anti\u2013eukaryotic initiation factor 2B autoantibodies are associated with interstitial lung disease in patients With systemic sclerosis. Arthritis Rheumatol 68:2778\u20132783. https:\/\/doi.org\/10.1002\/art.39755","journal-title":"Arthritis Rheumatol"},{"key":"7123_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","volume":"57","author":"JD Pauling","year":"2018","unstructured":"Pauling JD, Salazar G, Lu H et al (2018) Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis. Rheumatol (United Kingdom) 57:712\u2013717. https:\/\/doi.org\/10.1093\/rheumatology\/kex458","journal-title":"Rheumatol (United Kingdom)"},{"key":"7123_CR51","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/art.24586","volume":"61","author":"N Fertig","year":"2009","unstructured":"Fertig N, Domsic RT, Rodriguez-Reyna T et al (2009) Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Care Res 61:958\u2013965. https:\/\/doi.org\/10.1002\/art.24586","journal-title":"Arthritis Care Res"},{"key":"7123_CR52","unstructured":"Wirtz D, Schulte-Pelkum J, Budde P, et al (2015) Development of a qualitative ELISA for the detection of anti-BICD2 autoantibodies in systemic sclerosis. In: 12th Dresden Symposium on Autoantibodies, P53. Dresden"},{"key":"7123_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12016-021-08911-z","volume":"63","author":"EKL Chan","year":"2022","unstructured":"Chan EKL (2022) Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis. Clin Rev Allergy Immunol 63:178\u2013193. https:\/\/doi.org\/10.1007\/s12016-021-08911-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"7123_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/0961203316640918","volume":"25","author":"M Mahler","year":"2016","unstructured":"Mahler M, Swart A, Wu J et al (2016) Clinical and serological associations of autoantibodies to the Ku70\/Ku80 heterodimer determined by a novel chemiluminescent immunoassay. Lupus 25:889\u2013896. https:\/\/doi.org\/10.1177\/0961203316640918","journal-title":"Lupus"},{"key":"7123_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/ar2646","volume":"11","author":"M Mahler","year":"2009","unstructured":"Mahler M, Fritzler MJ (2009) The changing landscape of the clinical value of the PM\/Scl autoantibody system. Arthritis Res Ther 11:106. https:\/\/doi.org\/10.1186\/ar2646","journal-title":"Arthritis Res Ther"},{"key":"7123_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3899\/jrheum.101144","volume":"38","author":"PAI Airo\u2019CeribelliCavazzana","year":"2011","unstructured":"Airo\u2019CeribelliCavazzana PAI et al (2011) Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol 38:1329\u20131334. https:\/\/doi.org\/10.3899\/jrheum.101144","journal-title":"J Rheumatol"},{"key":"7123_CR57","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar4486","volume":"16","author":"P Moinzadeh","year":"2014","unstructured":"Moinzadeh P, Fonseca C, Hellmich M et al (2014) Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. Arthritis Res Ther 16:R53. https:\/\/doi.org\/10.1186\/ar4486","journal-title":"Arthritis Res Ther"},{"key":"7123_CR58","doi-asserted-by":"publisher","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","volume":"113","author":"GJ Xu","year":"2016","unstructured":"Xu GJ, Shah AA, Li MZ et al (2016) Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer. Proc Natl Acad Sci U S A 113:E7526\u2013E7534. https:\/\/doi.org\/10.1073\/pnas.1615990113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7123_CR59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/1346-8138.13252","volume":"43","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Asano Y, Taniguchi T et al (2016) Serum levels of interleukin-18-binding protein isoform a: clinical association with inflammation and pulmonary hypertension in systemic sclerosis. J Dermatol 43:912\u2013918. https:\/\/doi.org\/10.1111\/1346-8138.13252","journal-title":"J Dermatol"},{"key":"7123_CR60","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24:328\u2013332","journal-title":"J Rheumatol"},{"key":"7123_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1515\/rjim-2015-0006","volume":"53","author":"P B\u0103l\u0103nescu","year":"2015","unstructured":"B\u0103l\u0103nescu P, L\u0103daru A, B\u0103l\u0103nescu E et al (2015) IL-17, IL-6 and IFN-\u03b3 in systemic sclerosis patients. Rom J Intern Med 53:44\u201349. https:\/\/doi.org\/10.1515\/rjim-2015-0006","journal-title":"Rom J Intern Med"},{"key":"7123_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1684\/ecn.2013.0330","volume":"24","author":"E Robak","year":"2013","unstructured":"Robak E, Kulczycka-Siennicka L, Gerlicz Z et al (2013) Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients. Eur Cytokine Netw 24:60\u201368. https:\/\/doi.org\/10.1684\/ecn.2013.0330","journal-title":"Eur Cytokine Netw"},{"key":"7123_CR63","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13075-021-02678-6","volume":"23","author":"B Xu","year":"2021","unstructured":"Xu B, Xu G, Yu Y, Lin J (2021) The role of TGF-\u03b2 or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis. Arthritis Res Ther 23:288. https:\/\/doi.org\/10.1186\/s13075-021-02678-6","journal-title":"Arthritis Res Ther"},{"key":"7123_CR64","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.coph.2022.102211","volume":"64","author":"H Bukiri","year":"2022","unstructured":"Bukiri H, Volkmann ER (2022) Current advances in the treatment of systemic sclerosis. Curr Opin Pharmacol 64:102211. https:\/\/doi.org\/10.1016\/j.coph.2022.102211","journal-title":"Curr Opin Pharmacol"},{"key":"7123_CR65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1164\/rccm.202103-0714OC","volume":"205","author":"D Khanna","year":"2022","unstructured":"Khanna D, Lin CJF, Furst DE et al (2022) Long-term safety and efficacy of tocilizumab in early systemic sclerosis\u2013interstitial lung disease: open-label extension of a phase 3 randomized controlled trial. Am J Respir Crit Care Med 205:674\u2013684. https:\/\/doi.org\/10.1164\/rccm.202103-0714OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7123_CR66","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly S, Cant R, Ciechkomaka M, van Laar JM (2013) Interleukin-6: a new therapeutic target in systemic sclerosis? Clin Transl Immunol 2. https:\/\/doi.org\/10.1038\/cti.2013.2","DOI":"10.1038\/cti.2013.2"},{"key":"7123_CR67","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00234.2019","volume":"318","author":"G Jalce","year":"2020","unstructured":"Jalce G, Guignabert C (2020) Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension. Am J Physiol Cell Mol Physiol 318:L1\u2013L9. https:\/\/doi.org\/10.1152\/ajplung.00234.2019","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"7123_CR68","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.42111","volume":"74","author":"C Frantz","year":"2022","unstructured":"Frantz C, Cauvet A, Durand A et al (2022) Driving role of interleukin-2\u2013related regulatory CD4+ T cell deficiency in the development of lung fibrosis and vascular remodeling in a mouse model of systemic sclerosis. Arthritis Rheumatol 74:1387\u20131398. https:\/\/doi.org\/10.1002\/art.42111","journal-title":"Arthritis Rheumatol"},{"key":"7123_CR69","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/life12050698","volume":"12","author":"J Kosa\u0142ka-W\u0119giel","year":"2022","unstructured":"Kosa\u0142ka-W\u0119giel J, Licho\u0142ai S, Dziedzina S et al (2022) Genetic association between TNFA polymorphisms (rs1799964 and rs361525) and susceptibility to cancer in systemic sclerosis. Life 12:698. https:\/\/doi.org\/10.3390\/life12050698","journal-title":"Life"},{"key":"7123_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41435-023-00221-y","volume":"24","author":"V Lykhopiy","year":"2023","unstructured":"Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner SM (2023) IL-immunotherapy for targeting regulatory T cells in autoimmunity. Genes Immun 24:248\u2013262. https:\/\/doi.org\/10.1038\/s41435-023-00221-y","journal-title":"Genes Immun"},{"key":"7123_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2017.12.001","volume":"195","author":"J King","year":"2018","unstructured":"King J, Abraham D, Stratton R (2018) Chemokines in systemic sclerosis. Immunol Lett 195:68\u201375. https:\/\/doi.org\/10.1016\/j.imlet.2017.12.001","journal-title":"Immunol Lett"},{"key":"7123_CR72","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP et al (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201:650\u2013660. https:\/\/doi.org\/10.1164\/rccm.201903-0563CI","journal-title":"Am J Respir Crit Care Med"},{"key":"7123_CR73","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/14397595.2018.1480256","volume":"29","author":"T Furukawa","year":"2019","unstructured":"Furukawa T, Matsui K, Kitano M et al (2019) Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Mod Rheumatol 29:476\u2013483. https:\/\/doi.org\/10.1080\/14397595.2018.1480256","journal-title":"Mod Rheumatol"},{"key":"7123_CR74","doi-asserted-by":"publisher","first-page":"e000827","DOI":"10.1136\/bmjresp-2020-000827","volume":"8","author":"C Machahua","year":"2021","unstructured":"Machahua C, Guler SA, Horn MP et al (2021) Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts. BMJ Open Respir Res 8:e000827. https:\/\/doi.org\/10.1136\/bmjresp-2020-000827","journal-title":"BMJ Open Respir Res"},{"key":"7123_CR75","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.3389\/fimmu.2018.02998","volume":"9","author":"G Boleto","year":"2018","unstructured":"Boleto G, Allanore Y, Avouac J (2018) Targeting costimulatory pathways in systemic sclerosis. Front Immunol 9:2998. https:\/\/doi.org\/10.3389\/fimmu.2018.02998","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"7123_CR76","first-page":"133","volume":"37","author":"E Romano","year":"2019","unstructured":"Romano E, Rosa I, Fioretto BS et al (2019) A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems. Clin Exp Rheumatol 37(Suppl 1):133\u2013140","journal-title":"Clin Exp Rheumatol"},{"key":"7123_CR77","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/life12071056","volume":"12","author":"E Romano","year":"2022","unstructured":"Romano E, Rosa I, Fioretto BS et al (2022) Circulating neurovascular guidance molecules and their relationship with peripheral microvascular impairment in systemic sclerosis. Life 12:1056. https:\/\/doi.org\/10.3390\/life12071056","journal-title":"Life"},{"key":"7123_CR78","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13075-015-0749-4","volume":"17","author":"C Mazzotta","year":"2015","unstructured":"Mazzotta C, Romano E, Bruni C et al (2015) Plexin-D1\/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Arthritis Res Ther 17:221. https:\/\/doi.org\/10.1186\/s13075-015-0749-4","journal-title":"Arthritis Res Ther"},{"key":"7123_CR79","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5114\/ada.2018.75809","volume":"36","author":"M Michalska-Jakubus","year":"2019","unstructured":"Michalska-Jakubus M, Potembska E, Kowal M et al (2019) Clinical associations of serum leptin and leptin\/adiponectin ratio in systemic sclerosis. Postep Dermatologii Alergol 36:325\u2013338. https:\/\/doi.org\/10.5114\/ada.2018.75809","journal-title":"Postep Dermatologii Alergol"},{"key":"7123_CR80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","volume":"15","author":"Y Pehlivan","year":"2012","unstructured":"Pehlivan Y, Onat AM, Ceylan N et al (2012) Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 15:374\u2013379. https:\/\/doi.org\/10.1111\/j.1756-185X.2012.01755.x","journal-title":"Int J Rheum Dis"},{"key":"7123_CR81","doi-asserted-by":"publisher","first-page":"650605","DOI":"10.3389\/fphar.2021.650605","volume":"12","author":"V Sundblad","year":"2021","unstructured":"Sundblad V, Gomez RA, Stupirski JC et al (2021) Circulating galectin-1 and galectin-3 in sera from patients with systemic sclerosis: associations with clinical features and treatment. Front Pharmacol 12:650605. https:\/\/doi.org\/10.3389\/fphar.2021.650605","journal-title":"Front Pharmacol"},{"key":"7123_CR82","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/1346-8138.12810","volume":"42","author":"S Miura","year":"2015","unstructured":"Miura S, Asano Y, Saigusa R et al (2015) Serum vaspin levels: a possible correlation with digital ulcers in patients with systemic sclerosis. J Dermatol 42:528\u2013531. https:\/\/doi.org\/10.1111\/1346-8138.12810","journal-title":"J Dermatol"},{"key":"7123_CR83","doi-asserted-by":"publisher","first-page":"551","DOI":"10.5114\/ada.2018.79104","volume":"36","author":"K Sawicka","year":"2019","unstructured":"Sawicka K, Michalska-Jakubus M, Potembska E et al (2019) Visfatin and chemerin levels correspond with inflammation and might reflect the bridge between metabolism, inflammation and fibrosis in patients with systemic sclerosis. Postep Dermatologii i Alergol 36:551\u2013565. https:\/\/doi.org\/10.5114\/ada.2018.79104","journal-title":"Postep Dermatologii i Alergol"},{"key":"7123_CR84","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/ard-2022-223237","volume":"82","author":"S Sanges","year":"2023","unstructured":"Sanges S, Rice L, Tu L et al (2023) Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis. Ann Rheum Dis 82:365\u2013373. https:\/\/doi.org\/10.1136\/ard-2022-223237","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7123_CR85","doi-asserted-by":"publisher","first-page":"e88150","DOI":"10.1371\/journal.pone.0088150","volume":"6","author":"M Hasegawa","year":"2014","unstructured":"Hasegawa M, Asano Y, Endo H et al (2014) Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. PLoS One 6(9):e88150. https:\/\/doi.org\/10.1371\/journal.pone.0088150. (eCollection 2014)","journal-title":"PLoS One"},{"key":"7123_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.55563\/clinexprheumatol\/d03dnc","volume":"131","author":"P Kuszmiersz","year":"2021","unstructured":"Kuszmiersz P, Pacholczak-Madej R, Siwiec A et al (2021) Thrombin generation potential is enhanced in systemic sclerosis: impact of selected endothelial biomarkers. Clin Exp Rheumatol 131:13\u201319. https:\/\/doi.org\/10.55563\/clinexprheumatol\/d03dnc","journal-title":"Clin Exp Rheumatol"},{"key":"7123_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115282","author":"H Ren","year":"2023","unstructured":"Ren H, Liu L, Xiao Y et al (2023) Further insight into systemic sclerosis from the vasculopathy perspective. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.115282","journal-title":"Biomed Pharmacother"},{"key":"7123_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mvr.2017.06.003","volume":"114","author":"A Gigante","year":"2017","unstructured":"Gigante A, NavariniMargiotta LD et al (2017) Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy. Microvasc Res 114:41\u201345. https:\/\/doi.org\/10.1016\/j.mvr.2017.06.003","journal-title":"Microvasc Res"},{"key":"7123_CR89","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/14397595.2016.1206510","volume":"27","author":"JY Luo","year":"2017","unstructured":"Luo JY, Liu X, Jiang M et al (2017) Oxidative stress markers in blood in systemic sclerosis: a meta-analysis. Mod Rheumatol 27:306\u2013314. https:\/\/doi.org\/10.1080\/14397595.2016.1206510","journal-title":"Mod Rheumatol"},{"key":"7123_CR90","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.redox.2019.101122","volume":"25","author":"L Doridot","year":"2019","unstructured":"Doridot L, Jeljeli M, Ch\u1ec7ne C, Batteux F (2019) Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol 25:101122. https:\/\/doi.org\/10.1016\/j.redox.2019.101122","journal-title":"Redox Biol"},{"key":"7123_CR91","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/9783527692156.ch27","volume-title":"Inflammation\u2014from molecular and cellular mechanisms to the clinic","author":"A Cumpstey","year":"2017","unstructured":"Cumpstey A, Feelisch M (2017) Free radicals in inflammation. Inflammation\u2014from molecular and cellular mechanisms to the clinic. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp 695\u2013726"},{"key":"7123_CR92","doi-asserted-by":"publisher","first-page":"H214","DOI":"10.1152\/ajpheart.00310.2013","volume":"306","author":"S Chettimada","year":"2014","unstructured":"Chettimada S, Ata H, Rawat DK et al (2014) Contractile protein expression is upregulated by reactive oxygen species in aorta of Goto-Kakizaki rat. Am J Physiol Circ Physiol 306:H214\u2013H224. https:\/\/doi.org\/10.1152\/ajpheart.00310.2013","journal-title":"Am J Physiol Circ Physiol"},{"key":"7123_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0167-0115(00)00105-1","volume":"90","author":"S Dimmeler","year":"2000","unstructured":"Dimmeler S, Zeiher AM (2000) Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept 90:19\u201325. https:\/\/doi.org\/10.1016\/S0167-0115(00)00105-1","journal-title":"Regul Pept"},{"key":"7123_CR94","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2017.7083","volume":"27","author":"MM Cortese-Krott","year":"2017","unstructured":"Cortese-Krott MM, Koning A, Kuhnle GGC et al (2017) The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxid Redox Signal 27:684\u2013712. https:\/\/doi.org\/10.1089\/ars.2017.7083","journal-title":"Antioxid Redox Signal"},{"key":"7123_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/scdb.2001.0287","volume":"13","author":"PH Maxwell","year":"2002","unstructured":"Maxwell PH, Ratcliffe PJ (2002) Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13:29\u201337. https:\/\/doi.org\/10.1006\/scdb.2001.0287","journal-title":"Semin Cell Dev Biol"},{"key":"7123_CR96","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469\u20131480. https:\/\/doi.org\/10.1124\/mol.106.027029","journal-title":"Mol Pharmacol"},{"key":"7123_CR97","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JHW, Scheid A et al (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109\u2013116. https:\/\/doi.org\/10.1161\/01.RES.0000134644.89917.96","journal-title":"Circ Res"},{"key":"7123_CR98","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y et al (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124:175\u2013189. https:\/\/doi.org\/10.1016\/j.cell.2005.10.036","journal-title":"Cell"},{"key":"7123_CR99","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/art.23074","volume":"56","author":"JHW Distler","year":"2007","unstructured":"Distler JHW, J\u00fcngel A, Pileckyte M et al (2007) Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 56:4203\u20134215. https:\/\/doi.org\/10.1002\/art.23074","journal-title":"Arthritis Rheum"},{"key":"7123_CR100","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/1523-1747.ep12580445","volume":"89","author":"V Falanga","year":"1987","unstructured":"Falanga V, Tiegs SL, Alstadt SP et al (1987) Transforming growth factor-beta: Selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 89:100\u2013104. https:\/\/doi.org\/10.1111\/1523-1747.ep12580445","journal-title":"J Invest Dermatol"},{"key":"7123_CR101","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/ars.2011.4252","volume":"16","author":"M Bertolotti","year":"2012","unstructured":"Bertolotti M, Sitia R, Rubartelli A (2012) On the redox control of B lymphocyte differentiation and function. Antioxid Redox Signal 16:1139\u20131149. https:\/\/doi.org\/10.1089\/ars.2011.4252","journal-title":"Antioxid Redox Signal"},{"key":"7123_CR102","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","volume":"51","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly S, Hugle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology 51:1540\u20131549. https:\/\/doi.org\/10.1093\/rheumatology\/kes090","journal-title":"Rheumatology"},{"key":"7123_CR103","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biopha.2018.09.037","volume":"108","author":"C Mo","year":"2018","unstructured":"Mo C, Zeng Z, Deng Q et al (2018) Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis. Biomed Pharmacother 108:177\u2013183. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.037","journal-title":"Biomed Pharmacother"},{"key":"7123_CR104","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/ars.2014.5994","volume":"22","author":"JM Abais","year":"2015","unstructured":"Abais JM, Xia M, Zhang Y et al (2015) Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal 22:1111\u20131129. https:\/\/doi.org\/10.1089\/ars.2014.5994","journal-title":"Antioxid Redox Signal"},{"key":"7123_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-017-0417-1","volume":"9","author":"JN Taroni","year":"2017","unstructured":"Taroni JN, Greene CS, Martyanov V et al (2017) A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. Genome Med 9:27. https:\/\/doi.org\/10.1186\/s13073-017-0417-1","journal-title":"Genome Med"},{"key":"7123_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6064830","volume":"2016","author":"AT Dantas","year":"2016","unstructured":"Dantas AT, Gon\u00e7alves SMC, De AAR et al (2016) Reassessing the role of the active TGF- \u03b2 1 as a biomarker in systemic sclerosis: association of serum levels with clinical manifestations. Dis Markers 2016:1\u20136. https:\/\/doi.org\/10.1155\/2016\/6064830","journal-title":"Dis Markers"},{"key":"7123_CR107","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11596-008-0424-y","volume":"28","author":"C Meng","year":"2008","unstructured":"Meng C, Chen X, Li J et al (2008) Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications. J Huazhong Univ Sci Technol - Med Sci 28:480\u2013482. https:\/\/doi.org\/10.1007\/s11596-008-0424-y","journal-title":"J Huazhong Univ Sci Technol - Med Sci"},{"key":"7123_CR108","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","volume":"71","author":"M Manetti","year":"2012","unstructured":"Manetti M, Guiducci S, Romano E et al (2012) Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Ann Rheum Dis 71:1064\u20131072. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200837","journal-title":"Ann Rheum Dis"},{"key":"7123_CR109","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/rheumatology\/kei143","volume":"45","author":"Y Asano","year":"2006","unstructured":"Asano Y, Ihn H, Kubo M et al (2006) Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis. Rheumatology 45:303\u2013307. https:\/\/doi.org\/10.1093\/rheumatology\/kei143","journal-title":"Rheumatology"},{"key":"7123_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.185.1.71","volume":"185","author":"L Casciola-Rosen","year":"1997","unstructured":"Casciola-Rosen L, Wigley F, Rosen A (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 185:71\u201379. https:\/\/doi.org\/10.1084\/jem.185.1.71","journal-title":"J Exp Med"},{"key":"7123_CR111","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/rheumatology\/kem010","volume":"46","author":"Y Iwata","year":"2007","unstructured":"Iwata Y, Ogawa F, Komura K et al (2007) Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress. Rheumatology 46:790\u2013795. https:\/\/doi.org\/10.1093\/rheumatology\/kem010","journal-title":"Rheumatology"},{"key":"7123_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00403-009-0996-9","volume":"302","author":"F Ogawa","year":"2010","unstructured":"Ogawa F, Shimizu K, Hara T et al (2010) Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res 302:27\u201335. https:\/\/doi.org\/10.1007\/s00403-009-0996-9","journal-title":"Arch Dermatol Res"},{"key":"7123_CR113","doi-asserted-by":"publisher","first-page":"152228","DOI":"10.1016\/j.semarthrit.2023.152228","volume":"62","author":"R Dziedzic","year":"2023","unstructured":"Dziedzic R, W\u00f3jcik K, Olchawa M et al (2023) Increased oxidative stress response in circulating blood of systemic sclerosis patients\u2014relation to disease characteristics and inflammatory blood biomarkers. Semin Arthritis Rheum 62:152228. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152228","journal-title":"Semin Arthritis Rheum"},{"key":"7123_CR114","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/acr.22978","volume":"69","author":"ZH McMahan","year":"2017","unstructured":"McMahan ZH, Wigley FM, Casciola-Rosen L (2017) Risk of digital vascular events in scleroderma patients who have both anticentromere and anti\u2013interferon-inducible protein 16 antibodies. Arthritis Care Res 69:922\u2013926. https:\/\/doi.org\/10.1002\/acr.22978","journal-title":"Arthritis Care Res"},{"key":"7123_CR115","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/iwj.12882","volume":"15","author":"A Gigante","year":"2018","unstructured":"Gigante A, Margiotta D, Navarini L et al (2018) Serum level of endostatin and digital ulcers in systemic sclerosis patients. Int Wound J 15:424\u2013428. https:\/\/doi.org\/10.1111\/iwj.12882","journal-title":"Int Wound J"},{"key":"7123_CR116","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/rheumatology\/ket411","volume":"53","author":"E Schiopu","year":"2014","unstructured":"Schiopu E, Au KM, McMahon MA et al (2014) Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology 53:704\u2013713. https:\/\/doi.org\/10.1093\/rheumatology\/ket411","journal-title":"Rheumatology"},{"key":"7123_CR117","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/1076029617736382","volume":"24","author":"K Habe","year":"2018","unstructured":"Habe K, Wada H, Higashiyama A et al (2018) The plasma levels of ADAMTS-13, von Willebrand factor, VWFpp, and fibrin-related markers in patients with systemic sclerosis having thrombosis. Clin Appl Thromb 24:920\u2013927. https:\/\/doi.org\/10.1177\/1076029617736382","journal-title":"Clin Appl Thromb"},{"key":"7123_CR118","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/2397198319849805","volume":"4","author":"G Kovacs","year":"2019","unstructured":"Kovacs G, Olschewski H (2019) Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis. J Scleroderma Relat Disord 4:219\u2013224. https:\/\/doi.org\/10.1177\/2397198319849805","journal-title":"J Scleroderma Relat Disord"},{"key":"7123_CR119","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1684\/ejd.2011.1423","volume":"21","author":"HA Elshamy","year":"2011","unstructured":"Elshamy HA, Ibrahim SE, Farouk HM et al (2011) N-Terminal pro-brain natriuretic peptide in systemic sclerosis: new insights. Eur J Dermatology 21:686\u2013690. https:\/\/doi.org\/10.1684\/ejd.2011.1423","journal-title":"Eur J Dermatology"},{"key":"7123_CR120","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/23971983211040608","volume":"7","author":"M Jha","year":"2022","unstructured":"Jha M, Wang M, Steele R et al (2022) NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: findings from the Canadian Scleroderma Research Group. J Scleroderma Relat Disord 7:62\u201370. https:\/\/doi.org\/10.1177\/23971983211040608","journal-title":"J Scleroderma Relat Disord"},{"key":"7123_CR121","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar4457","volume":"16","author":"A Kill","year":"2014","unstructured":"Kill A, Tabeling C, Undeutsch R et al (2014) Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther 16:R29. https:\/\/doi.org\/10.1186\/ar4457","journal-title":"Arthritis Res Ther"},{"key":"7123_CR122","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/resp.13500","volume":"24","author":"MR Lammi","year":"2019","unstructured":"Lammi MR, Saketkoo LA, Okpechi SC et al (2019) Microparticles in systemic sclerosis: potential pro-inflammatory mediators and pulmonary hypertension biomarkers. Respirology 24:675\u2013683. https:\/\/doi.org\/10.1111\/resp.13500","journal-title":"Respirology"},{"key":"7123_CR123","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12265-012-9400-9","volume":"5","author":"KD Panse","year":"2012","unstructured":"Panse KD, Felkin LE, L\u00f3pez-Ola\u00f1eta MM et al (2012) Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes. J Cardiovasc Transl Res 5:814\u2013826. https:\/\/doi.org\/10.1007\/s12265-012-9400-9","journal-title":"J Cardiovasc Transl Res"},{"key":"7123_CR124","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcha.2015.06.006","volume":"8","author":"Y Izumiya","year":"2015","unstructured":"Izumiya Y, Jinnn M, Kimura Y et al (2015) Expression of Let-7 family microRNAs in skin correlates negatively with severity of pulmonary hypertension in patients with systemic scleroderma. IJC Hear Vasc 8:98\u2013102. https:\/\/doi.org\/10.1016\/j.ijcha.2015.06.006","journal-title":"IJC Hear Vasc"},{"key":"7123_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12061894","volume":"12","author":"Q Sun","year":"2020","unstructured":"Sun Q, Hackler J, Hilger J et al (2020) Selenium and copper as biomarkers for pulmonary arterial hypertension in systemic sclerosis. Nutrients 12:1\u201313. https:\/\/doi.org\/10.3390\/nu12061894","journal-title":"Nutrients"},{"key":"7123_CR126","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8:304\u2013320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1","journal-title":"Lancet Respir Med"},{"key":"7123_CR127","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","volume":"22","author":"L B\u00fctikofer","year":"2020","unstructured":"B\u00fctikofer L, Varisco PA, Distler O et al (2020) ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis\u2014a EUSTAR analysis. Arthritis Res Ther 22:59. https:\/\/doi.org\/10.1186\/s13075-020-2141-2","journal-title":"Arthritis Res Ther"},{"key":"7123_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40248-018-0155-2","volume":"13","author":"SE Torrisi","year":"2018","unstructured":"Torrisi SE, Palmucci S, Stefano A et al (2018) Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes. Multidiscip Respir Med 13:43. https:\/\/doi.org\/10.1186\/s40248-018-0155-2","journal-title":"Multidiscip Respir Med"},{"key":"7123_CR129","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10067-021-05698-4","volume":"40","author":"M Moradzadeh","year":"2021","unstructured":"Moradzadeh M, Aghaei M, Mehrbakhsh Z et al (2021) Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis. Clin Rheumatol 40:3897\u20133918. https:\/\/doi.org\/10.1007\/s10067-021-05698-4","journal-title":"Clin Rheumatol"},{"key":"7123_CR130","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/ijms24032963","volume":"24","author":"JE Mouawaid","year":"2023","unstructured":"Mouawaid JE, Feghali-Bostwick C (2023) The molecular mechanism of systemic sclerosis-associated lung fibrosis 24:2963. https:\/\/doi.org\/10.3390\/ijms24032963","journal-title":"The molecular mechanism of systemic sclerosis-associated lung fibrosis"},{"key":"7123_CR131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2021.04.020","volume":"91","author":"P Decker","year":"2021","unstructured":"Decker P, Moulinet T, Lopez B et al (2021) Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases. Eur J Intern Med 91:45\u201352. https:\/\/doi.org\/10.1016\/j.ejim.2021.04.020","journal-title":"Eur J Intern Med"},{"key":"7123_CR132","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","volume":"21","author":"JS Lee","year":"2019","unstructured":"Lee JS, Lee EY, Ha Y-J et al (2019) Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease. Arthritis Res Ther 21:58. https:\/\/doi.org\/10.1186\/s13075-019-1835-9","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"7123_CR133","doi-asserted-by":"publisher","first-page":"72745","DOI":"10.3389\/fphys.2021.727451","volume":"12","author":"E Leong","year":"2021","unstructured":"Leong E, Bezuhly M, Marshall JS (2021) Distinct metalloproteinase expression and functions in systemic sclerosis and fibrosis: what we know and the potential for intervention. Front Physiol 12(12):72745. https:\/\/doi.org\/10.3389\/fphys.2021.727451","journal-title":"Front Physiol"},{"key":"7123_CR134","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","volume":"20","author":"F Weigold","year":"2018","unstructured":"Weigold F, G\u00fcnther J, Pfeiffenberger M et al (2018) Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. Arthritis Res Ther 20:52. https:\/\/doi.org\/10.1186\/s13075-018-1545-8","journal-title":"Arthritis Res Ther"},{"key":"7123_CR135","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1080\/14397595.2020.1859726","volume":"31","author":"V Dichev","year":"2021","unstructured":"Dichev V, Mehterov NH, Kazakova MH et al (2021) Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis. Mod Rheumatol 31:1010\u20131018. https:\/\/doi.org\/10.1080\/14397595.2020.1859726","journal-title":"Mod Rheumatol"},{"key":"7123_CR136","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1034\/j.1399-3003.1999.14b23.x","volume":"14","author":"M Suga","year":"1999","unstructured":"Suga M, Iyonaga K, Ichiyasu H et al (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14:376\u2013382. https:\/\/doi.org\/10.1034\/j.1399-3003.1999.14b23.x","journal-title":"Eur Respir J"},{"key":"7123_CR137","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.berh.2019.01.005","volume":"32","author":"A Grosicka","year":"2018","unstructured":"Grosicka A, Manasar A, Kucharz EJ, Kotyla PJ (2018) Serum concentration of surfactant protein D in patients with systemic sclerosis: the potential marker of the interstitial lung disease severity. Best Pract Res Clin Rheumatol 32:541\u2013549. https:\/\/doi.org\/10.1016\/j.berh.2019.01.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7123_CR138","doi-asserted-by":"publisher","first-page":"e7083","DOI":"10.1097\/MD.0000000000007083","volume":"96","author":"K Wang","year":"2017","unstructured":"Wang K, Ju Q, Cao J et al (2017) Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis. Medicine (Baltimore) 96:e7083. https:\/\/doi.org\/10.1097\/MD.0000000000007083","journal-title":"Medicine (Baltimore)"},{"key":"7123_CR139","doi-asserted-by":"publisher","first-page":"E3901","DOI":"10.1073\/pnas.1523512113","volume":"113","author":"M Elhai","year":"2016","unstructured":"Elhai M, Avouac J, Hoffmann-Vold AM et al (2016) OX40L blockade protects against inflammationdriven fibrosis. Proc Natl Acad Sci U S A 113:E3901\u2013E3910. https:\/\/doi.org\/10.1073\/pnas.1523512113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7123_CR140","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00403-019-01893-1","volume":"311","author":"J \u017b\u00f3\u0142kiewicz","year":"2019","unstructured":"\u017b\u00f3\u0142kiewicz J, Stochmal A, Rudnicka L (2019) The role of adipokines in systemic sclerosis: a missing link? Arch Dermatol Res 311:251\u2013263. https:\/\/doi.org\/10.1007\/s00403-019-01893-1","journal-title":"Arch Dermatol Res"},{"key":"7123_CR141","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/rheumatology\/kez318","volume":"59","author":"K Kawabata","year":"2020","unstructured":"Kawabata K, Makino T, Makino K et al (2020) IL-16 expression is increased in the skin and sera of patients with systemic sclerosis. Rheumatol (United Kingdom) 59:519\u2013523. https:\/\/doi.org\/10.1093\/rheumatology\/kez318","journal-title":"Rheumatol (United Kingdom)"},{"key":"7123_CR142","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/jpm12101737","volume":"12","author":"G Leodori","year":"2022","unstructured":"Leodori G, Pellicano C, Basile V et al (2022) Serum adiponectin, a novel biomarker correlates with skin thickness in systemic sclerosis. J Pers Med 12:1737. https:\/\/doi.org\/10.3390\/jpm12101737","journal-title":"J Pers Med"},{"key":"7123_CR143","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/art.27220","volume":"62","author":"G Farina","year":"2010","unstructured":"Farina G, Lafyatis D, Lemaire R, Farina LG, R, (2010) A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 62:580\u2013588. https:\/\/doi.org\/10.1002\/art.27220","journal-title":"Arthritis Rheum"},{"key":"7123_CR144","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3899\/jrheum.190945","volume":"47","author":"EP Stern","year":"2020","unstructured":"Stern EP, Guerra SG, Chinque H et al (2020) Analysis of anti-RNA polymerase III antibody-positive systemic sclerosis and altered GPATCH2L and CTNND2 expression in scleroderma renal crisis. J Rheumatol 47:1668\u20131677. https:\/\/doi.org\/10.3899\/jrheum.190945","journal-title":"J Rheumatol"},{"key":"7123_CR145","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","volume":"18","author":"M Okr\u00f3j","year":"2016","unstructured":"Okr\u00f3j M, Johansson M, Saxne T et al (2016) Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis. Arthritis Res Ther 18:267. https:\/\/doi.org\/10.1186\/s13075-016-1168-x","journal-title":"Arthritis Res Ther"},{"key":"7123_CR146","doi-asserted-by":"publisher","first-page":"152185","DOI":"10.1016\/j.semarthrit.2023.152185","volume":"60","author":"AD Nguyen","year":"2023","unstructured":"Nguyen AD, Andr\u00e9asson K, McMahan ZH et al (2023) Gastrointestinal tract involvement in systemic sclerosis: the roles of diet and the microbiome. Semin Arthritis Rheum 60:152185. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152185","journal-title":"Semin Arthritis Rheum"},{"key":"7123_CR147","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2796.2010.02340.x","volume":"270","author":"K Andr\u00e9asson","year":"2011","unstructured":"Andr\u00e9asson K, Scheja A, Saxne T et al (2011) Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med 270:50\u201357. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02340.x","journal-title":"J Intern Med"},{"key":"7123_CR148","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1053\/gast.2002.36057","volume":"123","author":"F Goldblatt","year":"2002","unstructured":"Goldblatt F, Gordon TP, Waterman SA (2002) Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123:1144\u20131150. https:\/\/doi.org\/10.1053\/gast.2002.36057","journal-title":"Gastroenterology"},{"key":"7123_CR149","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00296-022-05264-4","volume":"43","author":"V Hamberg","year":"2023","unstructured":"Hamberg V, Wallman JK, Mogard E et al (2023) Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis. Rheumatol Int 43:961\u2013967. https:\/\/doi.org\/10.1007\/s00296-022-05264-4","journal-title":"Rheumatol Int"},{"key":"7123_CR150","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.rdc.2020.03.002","volume":"46","author":"E Weeding","year":"2020","unstructured":"Weeding E, Casciola-Rosen L, Shah AA (2020) Cancer and scleroderma. Rheum Dis Clin North Am 46:551\u2013564. https:\/\/doi.org\/10.1016\/j.rdc.2020.03.002","journal-title":"Rheum Dis Clin North Am"},{"key":"7123_CR151","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.jbspin.2023.105618","volume":"90","author":"A Guillen-Del-Castillo","year":"2023","unstructured":"Guillen-Del-Castillo A, Sime\u00f3n-Aznar CP (2023) Identifying the risk of cancer-associated systemic sclerosis. Joint Bone Spine 90:105618. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105618","journal-title":"Joint Bone Spine"},{"key":"7123_CR152","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65:1913\u20131921. https:\/\/doi.org\/10.1002\/art.37969","journal-title":"Arthritis Rheum"},{"key":"7123_CR153","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/1756-185X.13311","volume":"21","author":"G Sargin","year":"2018","unstructured":"Sargin G, Senturk T, Cildag S (2018) Systemic sclerosis and malignancy. Int J Rheum Dis 21:1093\u20131097. https:\/\/doi.org\/10.1111\/1756-185X.13311","journal-title":"Int J Rheum Dis"},{"key":"7123_CR154","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/rheumatology\/keab735","volume":"61","author":"S Hoa","year":"2022","unstructured":"Hoa S, Lazizi S, Baron M et al (2022) Association between autoantibodies in systemic sclerosis and cancer in a national registry. Rheumatology (Oxford) 61:2905\u20132914. https:\/\/doi.org\/10.1093\/rheumatology\/keab735","journal-title":"Rheumatology (Oxford)"},{"key":"7123_CR155","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.55563\/clinexperheumatol\/ki76s5","volume":"41","author":"M Di Battista","year":"2023","unstructured":"Di Battista M, Lepri G, Codullo V et al (2023) Systemic sclerosis: one year in review. Clin Exp Rheumatol 41:1567\u20131574. https:\/\/doi.org\/10.55563\/clinexperheumatol\/ki76s5","journal-title":"Clin Exp Rheumatol"},{"key":"7123_CR156","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/art.42524","volume":"75","author":"LK Hummers","year":"2023","unstructured":"Hummers LK (2023) Clinical trials in systemic sclerosis: crossroads and opportunities. Arthritis Rehumatol 75:1328\u20131330. https:\/\/doi.org\/10.1002\/art.42524","journal-title":"Arthritis Rehumatol"},{"key":"7123_CR157","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-021-02536-5","volume":"23","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro C, Allanore Y (2021) An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years. Arthritis Res Ther 23:155. https:\/\/doi.org\/10.1186\/s13075-021-02536-5","journal-title":"Arthritis Res Ther"},{"key":"7123_CR158","doi-asserted-by":"publisher","first-page":"keae150","DOI":"10.1093\/rheumatology\/keae150","volume":"9","author":"D Khanna","year":"2024","unstructured":"Khanna D, Kramer F, H\u00f6fler J et al (2024) Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 9:keae150. https:\/\/doi.org\/10.1093\/rheumatology\/keae150","journal-title":"Rheumatology (Oxford)"}],"updated-by":[{"DOI":"10.1007\/s10067-024-07147-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07123-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:08:13Z","timestamp":1727672893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07123-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":158,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7123"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07123-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-024-07147-4","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-024-07147-4","URL":"https:\/\/doi.org\/10.1007\/s10067-024-07147-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}